Recombinant Coagulation Factor VIII for Injection

Takeda Manufacturing Austria AG🇨🇳 National Medical Products Administration

Approval Id: 8Iee18PXZ88
Approval Number: 国药准字SJ20170021
Generic Name: 注射用重组人凝血因子Ⅷ
Generic Name En: Recombinant Coagulation Factor VIII for Injection
Trade Name: 百因止
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 500IU/瓶
Reg Date: 2023-12-20
Expired Date: 2027-07-28
Company Name: Takeda Manufacturing Austria AG
Production Company Name: Baxalta Manufacturing Sàrl
Company Detail Path: /organization/takeda-manufacturing-austria-ag
Production Company Detail Path: /organization/baxalta-manufacturing-sarl-neuchatel-switzerland

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 20, 2023

Approval ID

8Iee18PXZ88

Type

生物制品